These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

883 related articles for article (PubMed ID: 15182771)

  • 1. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).
    Bergström A; Andersson B; Edner M; Nylander E; Persson H; Dahlström U
    Eur J Heart Fail; 2004 Jun; 6(4):453-61. PubMed ID: 15182771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
    Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F
    Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
    Palazzuoli A; Quatrini I; Vecchiato L; Scali C; De Paola V; Iovine F; Martini G; Nuti R
    Minerva Cardioangiol; 2005 Aug; 53(4):321-8. PubMed ID: 16177676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol and nebivolol improve left ventricular systolic functions in patients with non-ischemic heart failure.
    Karabacak M; Doğan A; Tayyar Ş; Özaydın M; Erdoğan D
    Anatol J Cardiol; 2015 Apr; 15(4):271-6. PubMed ID: 25413223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older heart failure patients with preserved ejection fraction: study protocol for a randomized controlled trial.
    Park K; Park TH
    Trials; 2016 Nov; 17(1):530. PubMed ID: 27809882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure.
    Palazzuoli A; Carrera A; Calabria P; Puccetti L; Pastrorelli M; Pasqui AL; Auteri A; Bruni F
    Am Heart J; 2004 Jan; 147(1):E2. PubMed ID: 14691440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity.
    Nabati M; Janbabai G; Baghyari S; Esmaili K; Yazdani J
    J Cardiovasc Pharmacol; 2017 May; 69(5):279-285. PubMed ID: 28141699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
    Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
    Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
    J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular diastolic function improvement by carvedilol therapy in advanced heart failure.
    Palazzuoli A; Quatrini I; Vecchiato L; Calabria P; Gennari L; Martini G; Nuti R
    J Cardiovasc Pharmacol; 2005 Jun; 45(6):563-8. PubMed ID: 15897784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
    Otterstad JE; Ford I
    Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between systolic and diastolic function of the left ventricle in patients with impaired relaxation of the left ventricle without symptoms of heart failure. Attempt at quantitative estimation of diastolic function in the impaired relaxation stage].
    Kosmala W; Spring A; Witkowska M
    Pol Arch Med Wewn; 1997 Nov; 98(11):414-23. PubMed ID: 9594559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a standardized titration protocol with carvedilol in heart failure: safety, tolerability, and efficacy-a report from the GESICA registry.
    Nul D; Zambrano C; Diaz A; Ferrante D; Varini S; Soifer S; Grancelli H; Doval H;
    Cardiovasc Drugs Ther; 2005 Mar; 19(2):125-34. PubMed ID: 16025231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy.
    Rahko PS
    Echocardiography; 2005 Aug; 22(7):547-54. PubMed ID: 16060890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
    Paraskevaidis I; Farmakis D; Parissis JT; Dodouras T; Filippatos G; Tsiapras D; Kremastinos DT
    J Card Fail; 2007 Mar; 13(2):108-13. PubMed ID: 17395050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure.
    Lowes BD; Gill EA; Abraham WT; Larrain JR; Robertson AD; Bristow MR; Gilbert EM
    Am J Cardiol; 1999 Apr; 83(8):1201-5. PubMed ID: 10215284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure.
    Palazzuoli A; Bruni F; Puccetti L; Pastorelli M; Angori P; Pasqui AL; Auteri A
    Eur J Heart Fail; 2002 Dec; 4(6):765-70. PubMed ID: 12453548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.